Meriama Kufa Genamo

Mrs. Meriama Kufa Genamo

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2025 in Molecules
Verified
Journal Article
Open access
PDF file
MGMeriama Kufa Genamo
Meriama Kufa Genamo
AGAddisie Geremew
Addisie Geremew
EPElisha Peace
Elisha Peace
LCLaura Carson
Laura Carson
Vitamin-conjugated metallic nanoparticles (VC-MNPs) have emerged as a transformative platform in nanomedicine that combine the therapeutic potential of vitamins with the structural versatility of metal nanoparticles. They offer a dual advantage of targeted drug delivery and enhanced therapeutic efficacy, enabling precise intervention against infectious and malignant diseases. Vitamin conjugation facilitates receptor-mediated targeting, antioxidant enhancement, and improved biocompatibility, thereby strengthening therapeutic outcomes and reducing off-target effects. This review critically evaluates how vitamin functionalization modulates the synthesis, activity, and clinical translation of VC-MNPs. Diverse synthesis methods including chemical reduction, co-precipitation, sol–gel, and green approaches are evaluated, along with the influence of synthesis parameters on nanoparticle performance. The mechanisms underlying enhanced antimicrobial and anti-cancer efficacy are discussed, highlighting the contributions of vitamin functionalization to cellular uptake, redox balance and metabolic selectivity. Critical challenges in clinical translation are systematically assessed, including nanoparticle stability under physiological conditions, potential toxicity concerns, regulatory approval pathways, and manufacturing scalability requirements. Finally, the paper considers future perspectives, focusing on synthesis innovations, novel therapeutic targets, interdisciplinary collaborations, and pathways for clinical translation. Overall, VC-MNPs represent a promising next-generation platform for precision nanomedicine and sustainable therapeutic design.

18 September 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
MGMeriama Kufa Genamo
Meriama Kufa Genamo
AGAddisie Geremew
Addisie Geremew
EPElisha Peace
Elisha Peace
LCLaura Carson
Laura Carson
Vitamin-conjugated metallic nanoparticles (VC-MNPs) have emerged as a transformative platform in nanomedicine, offering a dual advantage of targeted drug delivery and enhanced therapeutic efficacy. This review highlights synthesis, characterization and recent advancements of VC-MNPs for biomedical applications, with a focus on antimicrobial and anti-cancer therapies. Diverse synthesis methods including chemical reduction, co-precipitation, sol-gel, and green approaches are evaluated, along with the influence of synthesis parameters on nanoparticle performance. The mechanisms underlying enhanced antimicrobial and anti-cancer efficacy are discussed, high-lighting the contributions of vitamin functionalization to cellular uptake and biocompatibility. The review elucidates the mechanistic basis for improved antimicrobial and anticancer activity, particularly focusing on how vitamin functionalization enhances cellular internalization and bio-compatibility profiles. Critical challenges in clinical translation are systematically assessed, including nanoparticle stability under physiological conditions, potential toxicity concerns, regulatory approval pathways, and manufacturing scalability requirements. Finally, the paper considers future perspectives, focusing on synthesis innovations, novel therapeutic targets, interdisciplinary collaborations, and pathways for clinical translation. Therefore, this review of recent advances promote vitamin conjugated metallic nanoparticles as a potent platform for next-generation drug delivery systems in medicine.